|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
WO1990003430A1
(en)
|
1988-09-23 |
1990-04-05 |
Cetus Corporation |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
AU673347B2
(en)
|
1992-03-17 |
1996-11-07 |
Novartis Ag |
Genetically engineered antibodies
|
|
DE69433747D1
(de)
|
1994-08-16 |
2004-06-03 |
Human Genome Sciences Inc |
Calcitoninrezeptor
|
|
US5785682A
(en)
|
1995-03-22 |
1998-07-28 |
Abbott Laboratories |
Pre-filled syringe drug delivery system
|
|
WO1998003534A1
(en)
|
1996-07-23 |
1998-01-29 |
Smithkline Beecham Corporation |
Calcitonin gene-related peptide receptor component factor (houdc44)
|
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
ATE370961T1
(de)
|
1998-05-06 |
2007-09-15 |
Genentech Inc |
Reinigung von antikörpern durch ionenaustauschchromatographie
|
|
ES2228052T3
(es)
|
1998-06-01 |
2005-04-01 |
Genentech, Inc. |
Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.
|
|
FR2821080B1
(fr)
|
2001-02-20 |
2003-12-19 |
Sanofi Synthelabo |
Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
|
|
DE60234944D1
(de)
|
2001-09-27 |
2010-02-11 |
Merck & Co Inc |
Isolierte dna-moleküle, die für einen humanisierten calcitonin gene-related peptide receptor kodiered assayverfahren
|
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
US20040110170A1
(en)
|
2002-05-18 |
2004-06-10 |
The Regents Of The University Of California |
Cloning and characterization of calcitonin gene related peptide receptors
|
|
MXPA05001649A
(es)
|
2002-08-12 |
2005-05-27 |
Birkir Sveinsson |
Uso de compuestos antagonistas del cgrp para tratamiento de la psoriasis.
|
|
US20040176577A1
(en)
|
2002-09-10 |
2004-09-09 |
Eva Rojer |
Immunoassays for specific determination of SCCA isoforms
|
|
WO2004097421A2
(en)
|
2003-04-29 |
2004-11-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl)
|
|
KR20140011431A
(ko)
|
2004-02-11 |
2014-01-28 |
아밀린 파마슈티칼스, 엘엘씨. |
선택가능한 특성을 갖는 하이브리드 폴리펩티드
|
|
AU2005310305A1
(en)
|
2004-10-22 |
2006-06-08 |
Amgen Inc. |
Methods for refolding polypeptides
|
|
EP1805320B1
(en)
|
2004-10-22 |
2014-09-03 |
Amgen Inc. |
Methods for refolding of recombinant antibodies
|
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
|
ZA200705695B
(en)
|
2004-12-21 |
2009-02-25 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
|
EP1900374B1
(en)
|
2005-06-16 |
2014-03-12 |
Takayuki Shindo |
Angiogenetic agent containing adrenomedulin as the active ingredient
|
|
GB0521139D0
(en)
|
2005-10-18 |
2005-11-23 |
Univ Sheffield |
Therapeutic agent
|
|
US8168592B2
(en)
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
|
SI3045182T1
(en)
|
2005-11-14 |
2018-08-31 |
Teva Pharmaceuticals International Gmbh |
An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
|
|
WO2007076336A1
(en)
|
2005-12-22 |
2007-07-05 |
Eli Lilly And Company |
Treatment of migraine with anti-cgrp antibodies
|
|
WO2008112004A2
(en)
|
2006-08-03 |
2008-09-18 |
Astrazeneca Ab |
ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
MX2010009724A
(es)
|
2008-03-04 |
2010-09-28 |
Pfizer Ltd |
Procedimientos de tratamiento del dolor inflamatorio-.
|
|
FR2934597B1
(fr)
|
2008-07-31 |
2013-04-19 |
Univ Aix Marseille Ii |
Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament.
|
|
CA2737045C
(en)
|
2008-11-20 |
2017-11-14 |
Bruce Kabakoff |
Therapeutic protein formulations
|
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
|
PE20120359A1
(es)
*
|
2009-03-06 |
2012-04-13 |
Genentech Inc |
Formulacion con anticuerpo
|
|
JP5540095B2
(ja)
*
|
2009-07-24 |
2014-07-02 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
抗体製造の最適化
|
|
BR112012004464B8
(pt)
|
2009-08-28 |
2021-05-25 |
Labrys Biologics Inc |
uso de um anticorpo antagonista anti-cgrp para preparar uma composição farmacêutica para tratar e/ou prevenir dor visceral e/ou um ou mais sintomas de dor visceral, em que a dor visceral está associada á cistite intersticial (ic), e dita composição farmacêutica
|
|
BR112012014937B1
(pt)
|
2009-12-18 |
2021-01-19 |
Novartis Ag |
método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade
|
|
JOP20190250A1
(ar)
|
2010-07-14 |
2017-06-16 |
Regeneron Pharma |
صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب
|
|
CN108014334B
(zh)
|
2011-05-20 |
2021-11-30 |
H.伦德贝克公司 |
抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途
|
|
JP6292718B2
(ja)
|
2011-07-01 |
2018-03-14 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
凝集ポリペプチドから単量体ポリペプチドを分離するための方法
|
|
CA2857194A1
(en)
|
2011-12-07 |
2013-06-13 |
Thomas M. Dillon |
Igg2 disulfide isoform separation
|
|
EP2791176B1
(en)
|
2011-12-15 |
2018-07-11 |
Prestige Biopharma Pte. Ltd. |
A method of antibody purification
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
KR102215405B1
(ko)
|
2013-03-15 |
2021-02-10 |
암젠 인크 |
인간 pac1 항체
|
|
TWI596107B
(zh)
*
|
2013-06-25 |
2017-08-21 |
卡地拉保健有限公司 |
單株抗體之新穎純化方法
|
|
KR102251127B1
(ko)
*
|
2013-07-12 |
2021-05-11 |
제넨테크, 인크. |
이온 교환 크로마토그래피 입력 최적화의 설명
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
MX378344B
(es)
|
2014-03-21 |
2025-03-10 |
Teva Pharmaceuticals Int Gmbh |
Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
|
|
US10556945B2
(en)
|
2014-03-21 |
2020-02-11 |
Teva Pharmaceuticals International Gmbh |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
|
UY36302A
(es)
|
2014-09-15 |
2016-04-29 |
Amgen Inc |
Proteína de unión a antígenos, bi-específicos del receptor anti-cgrp/receptor pac1 y usos de las mismas
|
|
TWI728953B
(zh)
|
2015-04-24 |
2021-06-01 |
美商安美基公司 |
治療或預防偏頭痛之方法
|
|
AR104847A1
(es)
|
2015-06-17 |
2017-08-16 |
Lilly Co Eli |
Formulación de anticuerpo anti-cgrp
|